Presentation Information

[3O0605-09-02]Preclinical evaluation of PfRipr5, a next-generation blood-stage malaria vaccine antigen with human-compatible adjuvants

○Eizo Takashima1, Hikaru Nagaoka1, Hidenori Kimura2, Akihisa Fukushima2, Takafumi Tsuboi3 (1. Division of Malaria Research, Proteo-Science Center, Ehime University, 2. Vaccines, Sumitomo Pharma Co., Ltd., 3. Division of Cell-free sciences, Proteo-Science Center, Ehime University)

Keywords:

Vaccine,Malaria

Password required to view


Comment

To browse or post comments, you must log in.Log in